Clinical Trials Directory

Trials / Terminated

TerminatedNCT05826561

Developing a Childhood Asthma Risk Passive Digital Marker

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Indiana University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Underdiagnosis and undertreatment is a major problem in childhood asthma management, especially in preschool-aged children. Current prognostic approaches using risk-score based tools have poor-to-modest accuracy, are impractical, and have limited evidence of efficacy in clinical settings and hence are not widely used in practice. The objective of the study is to determine the usability, acceptability, feasibility, and preliminary efficacy of the childhood asthma passive digital marker (PDM) among pediatricians. The study will include practicing pediatricians within the IU Health Network.

Conditions

Interventions

TypeNameDescription
OTHERChildhood Asthma Passive Digital MarkerA childhood asthma Passive Digital Marker (PDM) is an ML algorithm that is able to retrieve and synthesize pre-existing "passively" collected mother/child dyad prognostic data in "digital" electronic health record (EHR) to provide an objective and quantifiable "marker" of a child's risk (probability) and associated pathophysiological phenotype to inform clinician decision-making at point-of-care.

Timeline

Start date
2024-06-01
Primary completion
2025-06-16
Completion
2025-06-16
First posted
2023-04-24
Last updated
2025-07-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05826561. Inclusion in this directory is not an endorsement.